Residual Risk in CAD: What Remains, Why It Matters, What to Do 🫀⚠️💡

🫀 Residual Risk in Coronary Artery Disease Even after "optimal" therapy, many patients remain at risk. Why? Because atherosclerosis is more than LDL—it's thrombosis 🩸, inflammation 🔥, and metabolism ⚖️ working in concert.   This FAQ-based slide deck distills contemporary insights on residual thrombotic, lipid, metabolic, and inflammatory risk, and highlights emerging therapies—from dual-pathway inhibition 💊 to GLP-1 receptor agonists 🧬 and colchicine—that help close the gap between treatment and outcomes.   📊 Key message: precision, not complacency. #Cardiology #SecondaryPrevention #ResidualRisk #CAD #PrecisionMedicine